Abstract
Gene therapy is a very attractive strategy in experimental cancer therapy. Ideally, the approach aims to deliver therapeutic genes selectively to cancer cells. However, progress in the improvement of gene therapy formulations has been hampered by difficulties in measuring transgene delivery and in quantifying transgene expression in vivo. In clinical trials, endpoints rely almost exclusively on the analysis of biopsies, which provide limited information. Non-invasive monitoring of gene delivery and expression is a very attractive approach as it can be repeated over time in the same patient to provide spatiotemporal information on gene expression on a whole body scale. Thus, imaging methods can uniquely provide researchers and clinicians the ability to directly and serially assess morphological, functional and metabolic changes consequent to molecular and cellular based therapies. This review highlights the various methods currently being developed in preclinical models.
Similar content being viewed by others
References
Cui Y, Golob J, Kelleher E et al (2002) Targeting transgene expression to antigen-presenting cells derived from lentivirus-transduced engrafting human hematopoietic stem/progenitor cells. Blood 99:399–408
Tjuvajev JG, Stockhammer G, Desai R et al (1995) Imaging the expression of transfected genes in vivo. Cancer Res 55:6126–6132
Green LA, Yap CS, Nguyen K et al (2001) Indirect monitoring of endogenous gene expression by Positron Emission Tomography (PET) imaging of reporter gene expression in transgenic mice. Mol Imag Biol 4:71–81
Jacobs A, Voges J, Reszka R et al (2001) Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas. Lancet 358:727–729
Liang Q, Satyamurthy N, Barrio JR et al (2001) Noninvasive, quantitative imaging in living animals of a mutant dopamine D2 receptor reporter gene in which ligand binding is uncoupled from signal transduction. Gene Ther 8:1490–1498
Benali N, Cordelier P, Calise D et al (2000) Inhibition of growth and metastatic progression of pancreatic carcinoma in hamster after somatostatin receptor subtype 2 (sst2) gene expression and administration of cytotoxic somatostatin analog AN-238. Proc Natl Acad Sci U S A 97:9180–9185
DePuey EG (1996) New applications of myocardial perfusion imaging. Tex Heart Inst J 23:2
Gambhir S, Czernin J, Schwimmer J et al (2001) A tabulated summary of the FDG-PET literature. J Nucl Med 42:1S–71S
Elion GB (1993) Acyclovir: discovery, mechanism of action, and selectivity. J Med Virol [Suppl 1]:2–6
Banerjee D (1999) Technology evaluation: gene therapy (mesothelioma), NCI. Curr Opin Mol Ther 1:517–520
Tjuvajev JG, Avril N, Oku T et al (1998) Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography. Cancer Res 58:4333–4341
Bennett JJ, Tjuvajev J, Johnson P et al (2001) Positron emission tomography imaging for herpes virus infection: implications for oncolytic viral treatments of cancer. Nat Med 7:859–863
Hackman T, Dubrovin M, Balatoni J et al (2002) Monitoring E. coli cytosine deaminase gene expression by noninvasive imaging of the HSV-1-tk marker gene: potential clinical applications in cancer gene therapy. Mol Imaging 1:36–42
Vassaux G, Martín-Duque P (2004) Use of suicide genes for cancer gene therapy: study of the different approaches. Expert Opin Biol Ther 4: 519–530
Qiao J, Doubrovin M, Sauter BV et al (2002) Tumor-specific transcriptional targeting of suicide gene therapy. Gene Ther 9:168–175
Hackman T, Doubrovin M, Balatoni J et al (2002) Imaging expression of cytosine deaminase-herpes virus thymidine kinase fusion gene (CD/TK) expression with [124I]FIAU and PET. Mol Imaging 1:36–42
McLaren DC, Gambhir SS, Satyamurthy N et al (1999) Repetitive, non-invasive imaging of the dopamine D2 receptor as a reporter gene in living animals. Gene Ther 6:785–791
Liang Q, Satyamurthy N, Barrio JR et al (2001) Noninvasive, quantitative imaging in living animals of a mutant dopamine D2 receptor reporter gene in which ligand binding is uncoupled from signal transduction. Gene Ther 8:1490–1498
Gambhir SS, Herschman HR, Cherry SR et al (2000) Imaging transgene expression with radionuclide imaging technologies. Neoplasia 2:118–138
Bogdanov AA, Lewin M, Weissleder R (1999) Approaches and agents for imaging the vascular system. Adv Drug Deliv Rev 37:279–293
Schellingerhout D, Rainov NG, Breakefield XO, Weissleder R (2000) Quantitation of HSV mass distribution in a rodent brain tumor model. Gene Ther 7:1648–1655
Zinn KR, Chaudhuri TR (2002) The type 2 human somatostatin receptor as a platform for reporter gene imaging. Eur J Nucl Med Mol Imaging 29:388–399
Doubrovin M (2001) Imaging transcriptional regulation of p53-dependent genes with positron emission tomography in vivo. Proc Natl Acad Sci U S A 98:9300–9305
Groot-Wassink T, Aboagye EO, Wang Y et al (2004) Noninvasive imaging of the transcriptional promoter fragments in mice. Cancer Res 64:4906–4911
Merron A, Peerlinck I, Martín-Duque P et al (2007) SPECT/CT imaging of oncolytic adenovirus propagation in tumours in vivo using the Na/I symporter as a reporter gene. Gene Therapy (in press)
Benaron DA, Contag RR, Contang CH (1997) Imaging brain structure and function, infection and gene expression in the body using light. Philos Trans R Soc Lond B Biol Sci 352:755–761
Contag CH, Spilman SD, Contag PR et al (1997) Visualizing gene expression in living mammals using a bioluminescent reporter. Photochem Photobiol 66:523–531
Contag CH, Bachman MH (2002) Advances in vivo bioluminescence imaging of gene expression. Annu Rev Biomed Eng 4:235–260
Ray P, De A, Min JJ et al (2004) Imaging tri-fusion multimodality reporter gene expression in living subjects. Cancer Res 64:1323–1330
Contag CH, Contag PR, Mullins JI et al (1995) Photonic detection of bacterial pathogens in living hosts. Mol Microbiol 18:593–603
Lockley M, Fernandez M, Wang Y et al (2006) Activity of the adenoviral E1A deletion mutant dl922-947 in ovarian cancer: comparison with E1A wild-type viruses, bioluminescence monitoring, and intraperitoneal delivery in Icodextrin. Cancer Res 66:990–998
Rehemtulla A, Stegman LD, Cardozo SJ et al (2000) Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging. Neoplasia 2:491–495
Edinger M, Sweeney TJ, Tucker AA et al (1999) Noninvasive assessment of tumor cell proliferation in animal models. Neoplasia 1:303–310
Edinger M, Cao YA, Hornig YS et al (2002) Advancing animal models of neoplasia through in vivo bioluminescence imaging. Eur J Cancer 38:2128–2136
Wetterwald A, van der Pluijm G, Que I et al (2002) Optical imaging of cancer metastasis to bone marrow: a mouse model of minimal residual disease. Am J Pathol 160:1143–1153
Shah K, Tang Y, Breakefield XO, Weissleder R (2003) Real-time imaging of TRAIL-induced apoptosis of glioma tumors in vivo. Oncogene 22:6865–6872
Shah K, Jacobs A, Breakefield XO, Weissleder R (2004) Molecular imaging of gene therapy for cancer. Gene Ther 11:1175–1187
Modo M, Hoehn M, Bulte JW (2005) Cellular MR imaging. Mol Imaging 4:143–164
Weissleder R, Cheng HC, Bogdanova A, Bogdanova A Jr (1997) Magnetically labeled cells can be detected by MR imaging. J Magn Reson Med Imag 7:258–263
Franklin RJ, Blaschuk KL, Bearchell MC et al (1999) Magnetic resonance imaging of transplanted oligodendrocyte precursors in the rat brain. Neuroreport 10:3961–3965
de Vries IJM, Lesterhuis JW, Barentsz JO et al (2005) Magnetic resonance tracking of dendritic cells in melanoma cells for monitoring cellular therapy. Nat Biotechnol 23:1407–1413
Bulte JW, Ma LD, Magin R et al (1993) Selective MR imaging of labelled human peripheral blood mononuclear cells by liposome mediated incorporation of dextran-magnetite particles. Magn Reson Med 29:32–37
Josephsen L, Tung CH, Moore A, Weissleder R (1999) High efficiency intracellular magnetic labelling with novel superparamagnetic-Tat peptide conjugates. Bioconjug Chem 10:186–191
Bulte JWM, Zhang S, van Gelderen P et al (1999) Neurotransplantation of magnetically labelled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelination. Proc Natl Acad Sci U S A 96:15256–15261
Wilhelm C, Billotey C, Roger J et al (2003) Intracellular uptake of anionic superparamagnetic nanoparticles as a function of their surface coating. Biomaterials 24:1001–1011
Frank JA, Zywicke H, Jordan EK et al (2002) Magnetic intracellular labeling of mammalian cells by combining (FDA-approved) superparamagnetic iron oxide MR contrast agents and commonly used transfection agents. Acad Radiol 9:S484–488
Daldrup-Link HE, Rudellus M, Oostendorp RA et al (2003) Targeting of haematopoetic progenitor cells with MR contrast agents. Radiology 228:760–767
Giesel FL, Stroick M, Griebe M et al (2006) Gadofluorine M uptake in stem cells as a new magnetic resonance imaging tracking method. Invest Radiol 41:868–873
Hoehn M, Kustermann E, Blunk J et al (2002) Monitoring of implanted stems cell migration in vivo: a highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat. Proc Natl Acad Sci U S A 99: 16267–16272
Shapiro EM, Skrtic S, Sharer K et al (2004) MRI detection of single particles for cellular imaging. Proc Natl Acad Sci U S A 101:10901–10906.
Navon G, Panigel R, Valensin G (1986) Liposomes containing paramagnetic macromolecules as MRI contrast agents. Magn Reson Med 3: 876–880
Pirko I, Johnson A, Ciric B et al (2004) In vivo magnetic resonance imaging of immune cells in the central nervous system with superparamagnetic antibodies. FASEB J 18:179–182
Moore A, Medarova Z, Potthast A, Dai G (2004) In vivo targeting of underglycosylated MUC-1 tumor antigen using a multimodal imaging probe. Cancer Res 64:1821–1827
Bulte JW, Hoekstra Y, Kamman RL et al (1992) Specific MR imaging of human lymphocytes by monoclonal antibody-guided dextran-magnetite particles. Magn Reson Med 25:148–157
So PW, Kalber T, Herlihy AH, Bell JD (2006) Chemical biotinylation of cells for molecular imaging and cell tracking. Proc Int Soc Mag Med 14:1870
Räty JR, Liimatainen T, Wirth T et al (2006) Magnetic resonance imaging of viral particle biodistribution in vivo. Gene Therapy 13:1440
Allen M, Bulte JWM, Liepold L et al (2005) Paramagnetic viral nanoparticles as potential high-relaxivity magnetic resonance contrast agents. Magn Reson Med 54:807
Anderson EA, Isaacman S, Peabody DS et al (2006) Viral nanoparticles donning a paramagnetic coat: conjugation of MRI contrast agents to the MS2 capsid. Nano Lett 6:1160
Mulder JW, Strijkers GJ, Habets JW et al (2005) MR molecular imaging and fluorescence microscopy for identification of activated tumor endothelium using a bimodal lipidic nanoparticle. FASEB J 19:2008
Kang HW, Josephsen L, Petrovsky A et al (2002) Magnetic resonance imaging of inducible E-selectin expression in human endothelial cell culture. Bioconjug Chem 13:122
Kang HW, Torres D, Wald L et al (2006) Targeted imaging of human endothelial-specific marker in a model of adoptive cell transfer. Lab Invest 86:599
Sipkins DA, Cheresh DA, Kazemi MR et al (1998) Detection of tumor angiogenesis in vivo by alphavbeta3-targeted magnetic resonance imaging. Nat Med 4:623
Weissleder R, Moore A, Mahmood U et al (2000) In vivo magnetic resonance imaging of transgene expression. Nat Med 6:351
Ichikawa T, Högemann D, Saeki Y et al (2002) Free content MRI of transgene expression: correlation to therapeutic gene expression. Neoplasia 4:523–530
Genove G, DeMarco U, Xu H et al (2005) A new transgene reporter for in vivo magnetic resonance imaging. Nat Med 11:450–454
Cohen B, Dafni H, Meir G et al (2005) Ferritin as an endogenous MRI reporter for noninvasive imaging of gene expression in C6 glioma tumors. Neoplasia 7:109–117
Louie AY, Hüber MM, Ahrens ET et al (2000) In vivo visualization of gene expression using magnetic resonance imaging. Nat Biotech 18:321–325
Zhao M, Kircher MF, Josephson L, Weissleder R (2002) Differential conjugation of Tat peptide to superparamagnetic nanoparticles and its effect on cellular uptake. Bioconjug Chem 13:840–844
Weissleder R, Simonva M, Bogdanova A et al (1997) MR imaging and scintigraphy of gene expression through melanin induction. Radiology 204:425–429
Riley PA (2003) Melanogenesis and melanoma. Pigment Cell Res 16:548–552
Alfke H, Stoppler H, Nockern F et al (2003) In vitro MR imaging of regulated gene expression. Radiology 228:488–492
So PW, Hotee S, Herlihy AH, Bell JD (2005) Generic method for imaging transgene expression. Magn Reson Med 54:218–221
Tannous BA, Grimm J, Perry KF et al (2006) Metabolic biotinylation of cell surface receptors for in vivo imaging. Nat Methods 3:391–396
Madio D, Van-Gelderen P, DesPres D et al (1998) Invited. On the feasibility of MRI-guided focused ultrasound for local induction of gene expression. J Magn Reson Imaging 8:101–104
Tang M, Redemann C, Szoka F (1996) In vitro gene delivery by degraded polyamidoamine dendrimers. Bioconjug Chem 7:703–714
Qui B, El-Sharkawy AM, Paliwal V et al (2004) Simultaneous radiofrequency (RF) heating and magnetic resonance (MR) thermal mapping using an intravascular MR imaging/RF heating system. Magn Reson Med 54:226–230
Gao F, Qiu B, Kar S et al (2006) Intravascular magnetic resonance/radiofrequency may enhance gene therapy for prevention of in-stent neointimal hyperplasia. Acad Radiol 13:526–530
Yang X, Atalar E, Li D et al (2001) Magnetic resonance imaging permits in vivo monitoring of catheter-based vascular gene delivery. Circulation 104:1588–1590
Lawrie A, Brisken A, Francis S et al (1999) Ultrasound enhances reporter gene expression after transfection of vascular cells in vitro. Circulation 99:2617–2620
Ernst S, Ouyang F, Linder C et al (2004) Initial experience with remote catheter ablation using a novel magnetic navigation system: magnetic remote catheter ablation. Circulation 109:1472–1475
Thornton AS, Janse P, Theuns DA et al (2006) Magnetic navigation in AV nodal re-entrant tachycardia study: early results of ablation with one-and three-magnet catheters. Europace 8:225–230
Tallheden T, Nannmark U, Lorentzon M et al (2006) In vivo MR imaging of magnetically labeled human embryonic stem cells. Life Sci 79:999–1006
Arbab AS, Jordan EK, Wilson LB et al (2004) In vivo trafficking and targeted delivery of magnetically labeled stem cells. Hum Gene Ther 15: 351–360
Fodor PJ, Tomashefsky P, Funk C (1957) Enzyme levels in the growing and spontaneously regressing Flexner-Jobling carcinoma. II. ATPase and glycolysis. Arch Biochem Biophys 71(2): 403–413
Wang S, Mintz A, Mochizuki K et al (2007) Multimodality optical imaging and 18F-FDG uptake in wild-type p53-containing and p53-null human colon tumor xenografts. Cancer Biol Ther 6(10) (in press)
Kettunen MI, Gröhn OHJ (2005) Tumour gene therapy monitoring using magnetic resonance imaging and spectroscopy. Current Gene Ther 5:685–696
Walter G, Cordier L, Bloy D, Sweeney HL (2005) Noninvasive monitoring of gene correction in dystrophic muscle. Magn Reson Med 54: 1369–1376
Phelps ME (2000) Inaugural article: positron emission tomography provides molecular imaging of biological processes. Proc Natl Acad Sci USA 97:9226–9233
Phelps ME (2000) PET: the merging of biology and imaging into molecular imaging. J Nucl Med 41:661–681
Gulec SA, Hoenie E, Hostetter R, Schwartzentruber D (2007) PET probe-guided surgery: applications and clinical protocol. World J Surg Oncol 5:65
Blasberf RG, Tjuvajev JG (2003) Molecular-genetic imaging: current and future perspectives. J Clin Invest 111:1620–1629
Serganova I, Ponomarev V, Blasberg R (2007) Human reporter genes: potential use in clinical studies. Nucl Med Biol 34:791–807
Chao H, Mansfield SG, Bartel RC et al (2003) Phenotype correction of hemophilia A mice by spliceosome-mediated RNA trans-splicing. Nat Med 9:1015–1019
Liu X, Jiang Q, Mansfield SG et al (2002) Partial correction of endogenous DeltaF508 CFTR in human cystic fibrosis airway epithelia by spliceosome-mediated RNA trans-splicing. Nat Biotechnol 20:47–52
Bhaumik S, Walls Z, Puttaraju M et al (2004) Molecular imaging of gene expression in living subjects by spliceosome-mediated RNA transsplicing. Proc Natl Acad Sci U S A 23:8693–8698
Söling A, Simm A, Rainov NG (2002) Intracellular localization of Herpes simplex virus type I thymidine kinase fused to different fluorescent proteins depends on choice of fluorescent tag. FEBS Lett 527:153–158
Ray P, Wu AM, Gambhir SS (2003) Optical bioluminescence and positron emission tomography imaging of a novel fusion reporter gene in tumor xenografts of living mice. Cancer Res 63:1160–1165
Ponomarev V, Doubrovin M, Serganova I et al (2004) A novel triple-modality reporter gene for whole-body fluorescent, bioluminescent and nuclear non-invasive imaging. Eur J Nucl Med Mol Imaging 31:740–751
Ray P, De A, Min JJ et al (2004) Imaging tri-fusion multimodality reporter gene expression in living subjects. Cancer Res 64:1323–1330
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported by an unrestricted educational grant from Roche Farma S.A.
Rights and permissions
About this article
Cite this article
Belmar, C., So, P.W., Vassaux, G. et al. Non-invasive genetic imaging for molecular and cell therapies of cancer. Clin Transl Oncol 9, 703–714 (2007). https://doi.org/10.1007/s12094-007-0127-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12094-007-0127-z